Once again the Food and Drug Adminstration (FDA) is making things difficult for the electronic cigarette, in spite of their ever growing popularity and apparent safety record.

 

Spike Babaian, the President of the National Vaper's Club, which is an oganisation for consumers, set up to promote and protect the e-cigarette, says that the FDA have now twice blocked valuable research into the electronic cigarette.

 

The FDA claims that the e-cig is a drug delivery device, even after an American judge ruled that the e-cig, just like products such as nicotine replacement patches, is not a drug delivery device.

 

Spike feels that the reason for blocking the research may be financial.

 

If the research were funded and done through the FDA it would cost millions of dollars, whereas the National Vapor Club has had a quote of $76,000 for the new research, and the study could almost certainly be done for less than $100,000 if they do not have to go through the FDA.

 

Some scientists claim that the e-cig could be up to 1,000 times safer than tobacco cigarettes, and even the FDA's own assessment shows that nitrosamines in e-cigarettes are 1400 times lower than some brands of conventional cigarettes.

 

The FDA's continued reluctance to give the e-cig a more positive spin is beginning to be a mystery.